Proteomic study of serum proteins in a type 2 diabetes mellitus rat model by Chinese traditional medicine Tianqi Jiangtang Capsule administration

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 4, 2010, Pages 1011-1014

  Zhang, Shu Xiang ^a   Sun, Hui ^a   Sun, Wen Jun ^a   Jiao, Guo Zheng ^a   Wang, Xi Jun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

ELISA; MALDI TOF TOF MS; Serum proteins; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHINESE DRUG; HAPTOGLOBIN; IMMUNOGLOBULIN G2A; PREALBUMIN; PROTHROMBIN; SERUM AMYLOID P; TIANQI JIANGTANG CAPSULE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; RAT;

ALLOXAN; ANIMALS; BLOOD PROTEINS; CAPSULES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPTOGLOBINS; MEDICINE, CHINESE TRADITIONAL; PREALBUMIN; PROTEOMICS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77955581604     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.06.033     Document Type: Article

References (24)

1. Schauer P.R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., Eid G.M., Mattar S., Ramanathan R., Barinas-Mitchel E., Rao R.H., Kuller L., Kelley D. Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitus. Ann. Surg. 2003, 238:467-484.
2. Etgen G.J., Oldham B.A. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 2000, 49:684-688.
3. Del Prato S., Tiengo A. The importance of first phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes-Metab. Res. 2001, 17:164-174.
4. Wittmann Liebold B., Rüdiger Graack H., Pohl T. Two-dimensional gel electophoresis as tool for proteomic studies in combination with protein identification by mass spectrometry. Proteomics 2006, 6:4688-4703.
5. Cho W.C., Yip T.-T., Chung W.-S., Leung A.W., Cheng C.H., Yue K.K. Differential expression of proteins in kidney, eye, aorta and serum of diabetic and non-diabetic rats. J. Cell Biochem. 2006, 99:256-268.
6. Sundsten T., Ortsäter H. Proteomics in diabetes research. Mol. Cell. Endocrinol. 2009, 297:93-103.
7. Tsuneki H., Ishizuka M., Terasawa M., Wu J.B., Sasaoka T., Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BioMed. Central Pharmacol. 2004, 4:18.
8. Kiga C., Nakagawa T., Koizumi K., Sakurai H., Shibagaki Y., Ogawa K., Goto H., Saiki I. Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine. Hachimi-jio-gan, using SELDI ProteinChip platform. Biol. Pharm. Bull. 2005, 28:1031-1037.
9. Ai J., Wang N., Du J., Yang M., Liu P., Du Z., Yang B. Establishment of type 2 diabetic animal model in Wistar rats. Chin. Pharmacol. Bull. 2004, 20:1309-1312.
10. Ai J., Wang N., Yang M., Du Z.M., Zhang Y.C., Yang B.F. Development of Wistar rat model of insulin resistance. World J. Gastroenterol. 2005, 11:3675-3679.
11. Gorg A., Postel W., Gunther S. Two-dimensional electrophoresis with immobilized pH gradients of leaf proteins from barley (Hordeum vulgare): method, reproducibility and genetic aspects. Electrophoresis 1988, 9:531-546.
12. Gamble S.C., Dunn M.J., Wheeler C.H., Joiner M.C., AduPoku A., Arrand J.E. Expression of proteins coincident with inducible radioprotection in human lung epithelial cells. Cancer Res. 2000, 60:2146-2151.
13. Wang B.C., Pan Y.H., Meng D.Z., Zhu Y.X., Identification quantitative analysis of significantly accumulated proteins during the Arabidopsis seedling de-etiolation process. J. Integr. Plant Biol. 2006, 48:104-113.
14. Riaza S., Shahzad Alam S., Akhtar M.W. Proteomic identification of human serum biomarkers in diabetes mellitus type 2. J. Pharm. Biomed. Anal. 2010, 51:1103-1107.
15. Li X., Gong Y., Wang Y., Wu S., Cai Y., He P., Lu Z., Ying W.T., Zhang Y.J., Jiao L.Y. Comparison of alternative analytical techniques for the characterization of the human serum proteome in HUPO plasma proteome project. Proteomics 2005, 5:3423-3441.
16. Jiang M., Jia L., Jiang W., Hu X., Zhou H., Gao X., Lu Z., Zhang Z. Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochem. Biophys. Res. Commun. 2003, 309:196-200.
17. Szapary P.O., Rader D.J. The triglyceride-high-density lipoprotein axis: an important target of therapy?. Am. Heart J. 2004, 148:211-221.
18. Ginsberg H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 2000, 106:453-458.
19. Yamato K., Tamasawa N., Murakami H., Matsui J., Tanabe J., Suda T., Yasujima M. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patient: role of HDL and apolipoprotein A-I. Diabetes Res. Clin. Pr. 2005, 69:124-128.
20. Lindsay S., Krakoff J., Hanson R.L., Bennett P.H., Knowler W.C. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes 2001, 50:1598-1603.
21. Sundster T., Zethelius B., Berne C., Bergsten P. Plasma proteome changes in subjects with Type 2 diabetes mellitus with a low or high early insulin. Clin. Sci. 2008, 114:499-507.
22. Ho{double acute}ppener J.W., Nieuwenhuis M.G., Vroom T.M., Ahrén B., Lips C.J. Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?. Mol. Cell. Endocrinol. 2002, 197:205-212.
23. Asleh R., Levy A.P. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc. Health Risk Manag. 2005, 1:19-28.
24. Li W.L., Zheng H.C., Bukuru J., De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 2004, 92:1-21.